Добробут

43
Добробут
Добробут is an iOS app from MEDYCHNY TSENTR DOBROBUT-POLIKLINIKA, TOV in the Health & Fitness category, currently rated 3.1★ across 30 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 43: Emerging (early traction worth watching). For a Health & Fitness app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (50 MB) | +$4 |
| ⚙ Health & Fitness complexity ×1.40 | +$20K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating < 3.5 (weak) | -18% |
| 🏷 Health & Fitness category multiple | +10% |
| ⭐ Small user base (<1K ratings) | -8% |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Pre-traction · 37/100INDIE TIERlimited signal- 💰 Revenue: Marginal — $249 - $1560/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 3.1★ across 30 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Below-average rating (3.1★)METRIC | −$1,500 | |
| Mature app (10y old)METRIC | +$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (30 ratings)METRIC | −$300 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE🆕 What's New · v4.29.1
Profile & Insights
Identification
- App name
- Добробут
- Developer
- MEDYCHNY TSENTR DOBROBUT-POLIKLINIKA, TOV
- Bundle ID
- com.Eleks.Dobrobut
- App Store URL
- Open in App Store
- Category
- Health & Fitness
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $1.3K/mo
- Top-grossing rank
- Outside top 100 in US Health & Fitness
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth34 ratings+1600% lifetimeShow 3-year history estimate ▾
📝 About this app
Digital Dobrobut: application capabilities
Each user of the Dobrobut application in Ukraine can do the following online:… View full description on the official store →
What Worked™ · Development Pipeline
12 EVENTS TRACKEDMulti-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 5★ | 1 | 5★ this version |
| 🇧🇷 BR | 0★ | 0 | — |
| 🇨🇦 CA | 4★ | 3 | 4★ this version |
| 🇩🇪 DE | 4.8★ | 10 | 4.8★ this version |
| 🇫🇷 FR | 4.66667★ | 3 | 4.66667★ this version |
| 🇬🇧 GB | 5★ | 15 | 5★ this version |
| 🇮🇳 IN | 0★ | 0 | — |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇺🇸 US | 3.32353★ | 34 | 3.32353★ this version |
Track this app’s revenue
FREE📝 Description
95
Why low confidence: only 30 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.




